Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Wolfe Research Downgrades CrowdStrike Holdings to Peer Perform

Wolfe Research analyst Alex Zukin downgrades CrowdStrike Holdings (NASDAQ:CRWD) from Outperform to Peer Perform.
byBenzinga Newsdesk
December 1, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Wolfe Research analyst Alex Zukin downgrades CrowdStrike Holdings (NASDAQ:CRWD) from Outperform to Peer Perform.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Johnson & Johnson’s Late-Breaking Results From Its PALOMA-2 Study Of Subcutaneous Amivantamab In Combination With Lazertinib Show Clinically Meaningful Antitumor Response And Improved Safety Profile In Patients With EGFR-Mutated Non-Small Cell Lung Can…

By Benzinga Newsdesk
June 3, 2:33 PM
administration in new Phase 2 dataCHICAGO, June 3, 2024 /PRNewswire/ -- Johnson & Johnson announced today new data from the Phase 2 PALOMA-2 study evaluating subcutaneous (SC) amivantamab combined with lazertinib as

JNJ